March 20, 2024 Fed Grapples With Rate Decision Amid Inflation Concerns
March 19, 2024 Bank of Japan Ends Era of Negative Rates
March 18, 2024 Nvidia’s AI Breakthroughs Take Center Stage at GTC
Apple: AI Strategy To Help Fight DOJ, Kickstart Growth
Nvidia Stock Priced As If It Will Deliver Us The Moon
Amazon: Still Cheap Even After Robust Rally
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice
February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?
OKYO Pharma (OKYO) stock forecast for 2023
Updated: March 23, 2024 (07:57)
Sector: HealthcareThe share price of OKYO Pharma Limited (OKYO) now
50/200 Day Moving Average: $1.506 / $1.628
This figure corresponds to the Average Price over the previous 50/200 days. For OKYO Pharma stocks, the 50-day moving average is the resistance level today.
For OKYO Pharma stocks, the 200-day moving average is the resistance level today.
Are you interested in OKYO Pharma Limited stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the OKYO Pharma stock price in 2023. How much will one OKYO Pharma share be worth in 2023? Is it worth taking profit / loss on OKYO stock now or waiting? What are analysts' forecasts for OKYO Pharma stock?
We forecast OKYO Pharma stock performance using neural networks based on historical data on OKYO stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
OKYO Pharma Limited stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for OKYO Pharma analysts is $None. Today 200 Day Moving Average is the resistance level (1.628 $). 50 Day Moving Average is the resistance level (1.506 $).
Historical and forecast chart of OKYO Pharma Limited stock
The chart below shows the historical price of OKYO Pharma stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the OKYO stock price can be found in the table below.
OKYO Pharma Limited operates as a preclinical biopharmaceutical company in the United Kingdom. Its preclinical development program includes OK-101 for the treatment of dry eyes, uveitis, and allergic conjunctivitis; and OK-201 to treat corneal neuropathic pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome (ARDS). OKYO Pharma Limited was incorporated in 2018 and is headquartered in London, the United Kingdom.
OKYO Pharma (OKYO) Forecast for 2023
Month | Target | Pes. | Opt. | Vol., % |
---|
OKYO Pharma information and performance
MARTELLO COURT, ADMIRAL PARK, ST. PETER PORT, GG
Market capitalization of the OKYO Pharma Limited is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of OKYO shares in the company outstanding by the market price of one share.
EBITDA of OKYO Pharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
OKYO Pharma price target for 2023 by month
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.